Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alnylam Pharmaceuticals
(NQ:
ALNY
)
247.61
+4.29 (+1.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,579,313
Open
243.00
Bid (Size)
246.55 (1)
Ask (Size)
252.03 (2)
Prev. Close
243.32
Today's Range
242.07 - 250.11
52wk Range
141.97 - 252.87
Shares Outstanding
118,847,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
July 01, 2024
June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged.
Via
Benzinga
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
July 01, 2024
Via
Benzinga
Performance
YTD
+27.03%
+27.03%
1 Month
+64.58%
+64.58%
3 Month
+63.94%
+63.94%
6 Month
+27.03%
+27.03%
1 Year
+30.53%
+30.53%
More News
Read More
Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
June 30, 2024
Via
Benzinga
Peering Into Alnylam Pharmaceuticals's Recent Short Interest
June 27, 2024
Via
Benzinga
Behind the Scenes of Alnylam Pharmaceuticals's Latest Options Trends
June 12, 2024
Via
Benzinga
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
May 17, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 26, 2024
Via
Benzinga
Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
How Is The Market Feeling About Alnylam Pharmaceuticals?
April 19, 2024
Via
Benzinga
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
June 24, 2024
Via
InvestorPlace
Exposures
Product Safety
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
June 24, 2024
Via
InvestorPlace
Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge
June 24, 2024
Via
Benzinga
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
June 24, 2024
Via
Investor's Business Daily
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Via
Benzinga
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations
June 24, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
Masters In Trading - Saturday, June 22
June 22, 2024
Via
Talk Markets
Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today
June 14, 2024
Via
Benzinga
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
June 13, 2024
Via
Benzinga
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2024
Via
Benzinga
Alnylam Issues 2023 Corporate Responsibility Report
May 07, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
ALNY Stock Earnings: Alnylam Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
May 02, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
April 18, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.